Elarekibep

Elarekibep (PRS-060) (AZD1402) is a high affinity, slowly dissociating, long-acting full antagonist of IL-4Ra. Elarekibep can be used for the research of T2 endotype asthma[1].

Product Specifications

CAS Number

[2485020-60-6]

Product Name Alternative

PRS-060; AZD1402

UNSPSC

12352203

Target

Others

Type

Inhibitory Antibodies

Related Pathways

Others

Applications

COVID-19-immunoregulation

Field of Research

Inflammation/Immunology

Assay Protocol

https://www.medchemexpress.com/elarekibep.html

Purity

98.86

Solubility

10 mM in DMSO

Smiles

[Elarekibep]

Molecular Weight

(16.99 kDa)

References & Citations

[1]Gabriele Matschiner, et al. Elarekibep (PRS-060/AZD1402) : a new class of inhaled Anticalin medicine targeting IL-4Ra for T2 endotype asthma. J Allergy Clin Immunol. 2022 Dec 30; S0091-6749 (22) 02588-X.